Insider Transactions in Q2 2021 at Vista Gen Therapeutics, Inc. (VTGN)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
H. Ralph Snodgrass PRES./CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,391
+3.59%
|
$3,391
$1.95 P/Share
|
|
Jun 30
2021
|
Shawn Singh CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+9.93%
|
$5,000
$1.95 P/Share
|
|
Jun 30
2021
|
Jerrold Duane Dotson VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
89,742
+20.43%
|
$0
$0.97 P/Share
|
|
Jun 30
2021
|
Jerrold Duane Dotson VP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,044
+18.92%
|
$3,044
$1.95 P/Share
|
|
Jun 30
2021
|
Mark Alan Smith CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,260
+15.56%
|
$2,260
$1.95 P/Share
|
|
Apr 23
2021
|
Shawn Singh CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.02%
|
$5,000
$1.5 P/Share
|